{"created":"2023-05-15T14:59:08.869354+00:00","id":80252,"links":{},"metadata":{"_buckets":{"deposit":"2b57e605-13b6-4b9b-b90f-53535a6f51e3"},"_deposit":{"created_by":1,"id":"80252","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"80252"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00080252","sets":["1"]},"author_link":["882621","882620"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2020-05","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"5","bibliographicPageEnd":"187","bibliographicPageStart":"179","bibliographicVolumeNumber":"69","bibliographic_titles":[{"bibliographic_title":"RADIOISOTOPES"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"学術雑誌のオンライン検索を利用して、核医学で利用されるＲＩの種類や頻度の俯瞰を試みた。最近１０年において研究利用されるＲＩの多くは、ポジトロン放出核種や治療用のβ核種であり、診断と治療、すなわち、セラノスティクスを具現化するＲＩ利用が進展している傾向を得た。また、α核種の利用はこの１０年間における大きな変化の一つであり、核医学における新たな賦活剤として、今後の利用とそれに伴う成果報告の増加が期待される。","subitem_description_type":"Abstract"}]},"item_8_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本アイソトープ協会"}]},"item_8_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.3769/radioisotopes.69.179","subitem_relation_type_select":"DOI"}}]},"item_8_relation_17":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://www.jstage.jst.go.jp/article/radioisotopes/69/5/69_690505/_article/-char/ja/","subitem_relation_type_select":"URI"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0033-8303","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"永津, 弘太郎"}],"nameIdentifiers":[{"nameIdentifier":"882620","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nagatsu, Kotaro","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"882621","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"放射性同位体の医学的利用に関する概括とα線放出核種の適用についての新たな展開","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"放射性同位体の医学的利用に関する概括とα線放出核種の適用についての新たな展開"}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2020-07-30"},"publish_date":"2020-07-30","publish_status":"0","recid":"80252","relation_version_is_last":true,"title":["放射性同位体の医学的利用に関する概括とα線放出核種の適用についての新たな展開"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T21:38:46.423906+00:00"}